Clinical Trial Update: Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tolvaptan for worsening outpatient heart failure and the role of copeptin in identifying responders; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Congestive Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2022-05-05